Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development

Basic Research in Cardiology

Volumn 108, Issue 4, 2013, Pages

  Fujiu, Katsuhito ^a,b   Nagai, Ryozo ^a,c,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac fibroblast; Cardiomyocyte; Cell cell interaction; Heart failure; Immune cell

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; ETANERCEPT; INTERLEUKIN 10; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIAC FIBROBLAST; CELL COMMUNICATION; CELL INTERACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOTHELIUM CELL; FIBROBLAST; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART STRESS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; NATURAL KILLER T CELL; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

EID: 84878406114     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-013-0357-x     Document Type: Article

References (119)

1. Accornero F, van Berlo JH, Benard MJ, Lorenz JN, Carmeliet P, Molkentin JD (2011) Placental growth factor regulates cardiac adaptation and hypertrophy through a paracrine mechanism. Circ Res 109:272-280. doi: 10.1161/CIRCRESAHA. 111.240820
2. Adam O, Lohfelm B, Thum T, Gupta SK, Puhl SL, Schafers HJ, Bohm M, Laufs U (2012) Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res Cardiol 107:278. doi: 10.1007/s00395-012-0278-0
3. Afzali B, Lombardi G, Lechler RI, Lord GM (2007) The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 148:32-46. doi: 10.1111/j.1365-2249.2007. 03356.x (Pubitemid 46365005)
4. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD (1997) Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-179. doi: 10.1172/jci119509 (Pubitemid 27311255)
5. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745-756. doi: 10.1038/nri1184 (Pubitemid 41070815)
6. Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, Kaneko H, Sugano Y, Takahashi T, Abe H, Mochizuki S, Sano M, Yoshikawa T, Okada Y, Koyasu S, Ogawa S, Fukuda K (2012) Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 125:1234-1245. doi: 10.1161/circulationaha.111.052126
7. Avalos AM, Apablaza FA, Quiroz M, Toledo V, Pena JP, Michea L, Irarrazabal CE, Carrion FA, Figueroa FE (2012) IL-17A levels increase in the infarcted region of the left ventricle in a rat model of myocardial infarction. Biol Res 45:193-200. doi: 10.1590/S0716-97602012000200012
8. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA (2007) Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 293:H1883-H1891. doi: 10.1152/ajpheart.00514.2007 (Pubitemid 47367239)
9. Bowers SL, Borg TK, Baudino TA (2010) The dynamics of fibroblast-myocyte-capillary interactions in the heart. Ann NY Acad Sci 1188:143-152. doi: 10.1111/j.1749-6632.2009.05094.x
10. Brower GL, Janicki JS (2005) Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats. J Card Fail 11:548-556. doi: 10.1016/j.cardfail.2005.05.005 (Pubitemid 41399896)
11. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, Salmon M (2001) Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 22:199-204. doi: 10.1016/S1471-4906(01) 01863-4 (Pubitemid 32673659)
12. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG (2008) Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 173:57-67. doi: 10.2353/ajpath.2008.070974 (Pubitemid 351947955)
13. Cai ZP, Parajuli N, Zheng X, Becker L (2012) Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Basic Res Cardiol 107:277. doi: 10.1007/s00395-012-0277-1
14. Chandrasekar B, Mitchell DH, Colston JT, Freeman GL (1999) Regulation of CCAAT/enhancer binding protein, interleukin-6, interleukin-6 receptor, and gp130 expression during myocardial ischemia/reperfusion. Circulation 99:427-433. doi: 10.1161/01.CIR.99.3.427 (Pubitemid 29051270)
15. Colombo F, Gosselin H, El-Helou V, Calderone A (2003) Beta-adrenergic receptor-mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3-kinase dependent pathway refractory to the antiproliferative action of cyclic AMP. J Cell Physiol 195:322-330. doi: 10.1002/jcp.10251 (Pubitemid 36384305)
16. Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M, Barnes JL, Chandrasekar B (2007) IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta, NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol 293:H3356-H3365. doi: 10.1152/ajpheart.00928.2007 (Pubitemid 350230876)
17. D'Souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A, Ferdinandy P, Baxter GF (2003) B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 284:H1592-H1600. doi: 10.1152/ajpheart.00902.2002
18. Dörge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G (2002) Coronary microembolization: the role of TNF-α in contractile dysfunction. J Mol Cell Cardiol 34:51-62. doi: 10.1006/jmcc.2001.1489 (Pubitemid 34146395)
19. Dean RG, Balding LC, Candido R, Burns WC, Cao Z, Twigg SM, Burrell LM (2005) Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J Histochem Cytochem 53:1245-1256. doi: 10.1369/jhc.4A6560.2005 (Pubitemid 41331123)
20. Del Re DP, Matsuda T, Zhai P, Gao S, Clark GJ, Van Der Weyden L, Sadoshima J (2010) Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice. J Clin Invest 120:3555-3567. doi: 10.1172/JCI43569
21. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG (2001) Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 33:1191-1207. doi: 10.1006/jmcc.2001.1383 (Pubitemid 32579285)
22. Deten A, Volz HC, Briest W, Zimmer HG (2002) Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55:329-340. doi: 10.1016/S0008-6363(02)00413-3 (Pubitemid 34775283)
23. Dhingra S, Sharma AK, Arora RC, Slezak J, Singal PK (2009) IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis. Cardiovasc Res 82:59-66. doi: 10.1093/cvr/cvp040
24. Divakaran V, Adrogue J, Ishiyama M, Entman ML, Haudek S, Sivasubramanian N, Mann DL (2009) Adaptive and maladaptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading. Circ Heart Fail 2:633-642. doi: 10.1161/CIRCHEARTFAILURE.108.823070
25. Erlich JH, Boyle EM, Labriola J, Kovacich JC, Santucci RA, Fearns C, Morgan EN, Yun W, Luther T, Kojikawa O, Martin TR, Pohlman TH, Verrier ED, Mackman N (2000) Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 157:1849-1862. doi: 10.1016/S0002-9440(10)64824-9
26. Feng W, Li W, Liu W, Wang F, Li Y, Yan W (2009) IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. Exp Mol Pathol 87:212-218. doi: 10.1016/j.yexmp.2009.06.001
27. Feng Y, Hans C, McIlwain E, Varner KJ, Lazartigues E (2012) Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy. PLoS One 7:e48910. doi: 10.1371/journal.pone.0048910
28. Fischer P, Hilfiker-Kleiner D (2007) Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res Cardiol 102:393-411. doi: 10.1007/s00395-007-0674-z (Pubitemid 47278812)
29. Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML (2000) IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 165:2798-2808 (Pubitemid 30660731)
30. Fredj S, Bescond J, Louault C, Delwail A, Lecron JC, Potreau D (2005) Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. J Cell Physiol 204:428-436. doi: 10.1002/jcp.20307 (Pubitemid 40934637)
31. Fredj S, Bescond J, Louault C, Potreau D (2005) Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation. J Cell Physiol 202:891-899. doi: 10.1002/Jcp.20197 (Pubitemid 40175867)
32. Friedrichs GS, Swillo RE, Jow B, Bridal T, Numann R, Warner LM, Killar LM, Sidek K (2002) Sphingosine modulates myocyte electrophysiology, induces negative inotropy, and decreases survival after myocardial ischemia. J Cardiovasc Pharmacol 39:18-28. doi: 10.1097/00005344-200201000-00003 (Pubitemid 34028549)
33. Glenn DJ, Rahmutula D, Nishimoto M, Liang F, Gardner DG (2009) Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism. Cardiovasc Res 84:209-217. doi: 10.1093/cvr/cvp208
34. Golias C, Tsoutsi E, Matziridis A, Makridis P, Batistatou A, Charalabopoulos K (2007) Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease. In Vivo 21:757-769
35. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS (1998) Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 40:352-363. doi: 10.1161/01.CIR.101.20.2338 (Pubitemid 28506046)
36. Gruhle S, Sauter M, Szalay G, Ettischer N, Kandolf R, Klingel K (2012) The prostacyclin agonist iloprost aggravates fibrosis and enhances viral replication in enteroviral myocarditis by modulation of ERK signaling and increase of iNOS expression. Basic Res Cardiol 107:287. doi: 10.1007/s00395-012-0287-z
37. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF (1989) Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 86:6753-6757. doi: 10.1073/pnas.86.17. 6753 (Pubitemid 19236340)
38. Hao J, Wang B, Jones SC, Jassal DS, Dixon IMC (2000) Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol 279:H3020-H3030
39. Heine HL, Leong HS, Rossi FM, McManus BM, Podor TJ (2005) Strategies of conditional gene expression in myocardium: an overview. Methods Mol Med 112:109-154. doi: 10.1007/978-1-59259-879-3-8
40. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589-600. doi: 10.1016/j.cell.2006.12.036 (Pubitemid 46206082)
41. Hu Y, Zhang H, Lu Y, Bai H, Xu Y, Zhu X, Zhou R, Ben J, Xu Y, Chen Q (2011) Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization. Basic Res Cardiol 106:1311-1328. doi: 10.1007/s00395-011-0204-x
42. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM, Srivastava D (2009) Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell 16:233-244. doi: 10.1016/j.devcel.2008.12.007
43. Jacobs M, Staufenberger S, Gergs U, Meuter K, Brandstatter K, Hafner M, Ertl G, Schorb W (1999) Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts. J Mol Cell Cardiol 31:1949-1959. doi: 10.1006/jmcc.1999.1007 (Pubitemid 29537595)
44. Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S, Monassier L, Mettauer B, Blaxall BC, Launay JM, Maroteaux L (2009) Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res 104:113-123. doi: 10.1161/CIRCRESAHA.108.180976
45. Joseph NM, Mosher JT, Buchstaller J, Snider P, McKeever PE, Lim M, Conway SJ, Parada LF, Zhu Y, Morrison SJ (2008) The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 13:129-140. doi: 10.1016/j.ccr.2008.01.003 (Pubitemid 351163162)
46. Kakkar R, Lee RT (2010) Intramyocardial fibroblast myocyte communication. Circ Res 106:47-57. doi: 10.1161/circresaha.109.207456
47. Kaneko K, Kanda T, Yokoyama T, Nakazato Y, Iwasaki T, Kobayashi I, Nagai R (1997) Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction. Res Commun Mol Pathol Pharmacol 97:3-12 (Pubitemid 27362624)
48. 2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med 38:217-222. doi: 10.1097/CCM.0b013e3181b4a854
49. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL (1997) Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 81:187-195. doi: 10.1161/01.RES.81.2.187 (Pubitemid 27342485)
50. Kapoun AM, Liang F, O'Young G, Damm DL, Quon D, White RT, Munson K, Lam A, Schreiner GF, Protter AA (2004) B-type natriuretic peptide exerts broad functional opposition to transforming growth factor-beta in primary human cardiac fibroblasts: fibrosis, myofibroblast conversion, proliferation, and inflammation. Circ Res 94:453-461. doi: 10.1161/01.RES.0000117070.86556.9F (Pubitemid 38326280)
51. Kaur K, Sharma AK, Singal PK (2006) Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol 291:H106-H113. doi: 10.1152/ajpheart.01327.2005
52. Kishimoto I, Rossi K, Garbers DL (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98:2703-2706. doi: 10.1073/pnas.051625598 (Pubitemid 32209546)
53. Kleinbongard P, Heusch G, Schulz R (2010) TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 127:295-314. doi: 10.1016/j.pharmthera.2010.05.002
54. Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA (2011) Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathological response to sustained pressure overload. J Clin Invest 121:2301-2312. doi: 10.1172/JCI44824
55. 2+ transients. FEBS Lett 376:24-30. doi: 10.1016/0014-5793(95) 01238-5 (Pubitemid 3003750)
56. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98:2854-2865. doi: 10.1172/JCI119114
57. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K, Imaizumi T (2004) Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43:739-745. doi: 10.1161/01.HYP.0000118584. 33350.7d (Pubitemid 38405580)
58. Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S, Gratze P, Dechend R, Luft FC, Muller DN (2009) Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation 119:2904-2912. doi: 10.1161/CIRCULATIONAHA.108.832782
59. LaFramboise WA, Scalise D, Stoodley P, Graner SR, Guthrie RD, Magovern JA, Becich MJ (2007) Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am J Physiol Cell Physiol 292:C1799-C1808. doi: 10.1152/ajpcell.00166. 2006 (Pubitemid 47080551)
60. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236-241. doi: 10.1056/NEJM199007263230405 (Pubitemid 20225044)
61. Liao CH, Akazawa H, Tamagawa M, Ito K, Yasuda N, Kudo Y, Yamamoto R, Ozasa Y, Fujimoto M, Wang P, Nakauchi H, Nakaya H, Komuro I (2010) Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. J Clin Invest 120:242-253. doi: 10.1172/JCI39942
62. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, Pu H, Saffitz J, Chien K, Xiao RP, Kass DA, Wang Y (2001) The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 98:12283-12288. doi: 10.1073/pnas.211086598 (Pubitemid 32959865)
63. Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, Lv BJ, Nie SF, Wang J, Iwakura Y, Xiao H, Yuan J, Jevallee H, Wei F, Shi GP, Cheng X (2012) Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol 59:420-429. doi: 10.1016/j.jacc.2011.10.863
64. Long CS, Hartogensis WE, Simpson PC (1993) Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium. J Mol Cell Cardiol 25:915-925. doi: 10.1006/jmcc.1993.1104 (Pubitemid 23317719)
65. Mann DL (2002) Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91:988-998. doi: 10.1161/01.RES.0000043825.01705.1B (Pubitemid 35416635)
66. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109:1594-1602. doi: 10.1161/01.CIR.0000124490.27666.B2 (Pubitemid 38451714)
67. Marra F, Aleffi S, Galastri S, Provenzano A (2009) Mononuclear cells in liver fibrosis. Semin Immunopathol 31:345-358. doi: 10.1007/s00281-009-0169-0
68. Matsui Y, Sadoshima J (2004) Rapid upregulation of CTGF in cardiac myocytes by hypertrophic stimuli: implication for cardiac fibrosis and hypertrophy. J Mol Cell Cardiol 37:477-481. doi: 10.1016/j.yjmcc.2004.05.012 (Pubitemid 38953375)
69. McMullen JR (2008) Role of insulin-like growth factor 1 and phosphoinositide 3-kinase in a setting of heart disease. Clin Exp Pharmacol Physiol 35:349-354. doi: 10.1111/j.1440-1681.2007.04873.x (Pubitemid 351257887)
70. McTiernan CF, Lemster BH, Frye C, Brooks S, Combes A, Feldman AM (1997) Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes. Circ Res 81:493-503. doi: 10.1161/01.RES.81.4.493 (Pubitemid 27432736)
71. Miller C, Cai Y, Oikawa M, Thomas T, Dostmann W, Zaccolo M, Fujiwara K, Yan C (2011) Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart. Basic Res Cardiol 106:1023-1039. doi: 10.1007/s00395-011-0228-2
72. Mitchell MD, Laird RE, Brown RD, Long CS (2007) IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways. Am J Physiol Heart Circ Physiol 292:H1139-H1147. doi: 10.1152/ajpheart.00881.2005
73. Murray DR, Prabhu SD, Chandrasekar B (2000) Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 101:2338-2341. doi: 10.1161/01.CIR.101.20.2338 (Pubitemid 30329120)
74. Novoyatleva T, Schymura Y, Janssen W, Strobl F, Swiercz JM, Patra C, Posern G, Wietelmann A, Zheng TS, Schermuly RT, Engel FB (2013) Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction. Basic Res Cardiol 108:325. doi: 10.1007/s00395-012-0325-x
75. Parajuli N, Yuan Y, Zheng X, Bedja D, Cai Z (2012) Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway. Basic Res Cardiol 107:248. doi: 10.1007/s00395-012-0248-6
76. Pawlinski R, Tencati M, Hampton CR, Shishido T, Bullard TA, Casey LM, Andrade-Gordon P, Kotzsch M, Spring D, Luther T, Abe J, Pohlman TH, Verrier ED, Blaxall BC, Mackman N (2007) Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation 116:2298-2306. doi: 10.1161/CIRCULATIONAHA.107.692764 (Pubitemid 350100336)
77. Pedrotty DM, Klinger RY, Kirkton RD, Bursac N (2009) Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes. Cardiovasc Res 83:688-697. doi: 10.1093/Cvr/Cvp164
78. Peng H, Yang X-P, Carretero OA, Nakagawa P, D'Ambrosio M, Leung P, Xu J, Peterson EL, González GE, Harding P, Rhaleb N-E (2011) Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice. Exp Physiol 96:756-764. doi: 10.1113/expphysiol.2011.057612
79. Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H (2003) Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 107:798-802. doi: 10.1161/01.CIR.0000057545.82749.FF (Pubitemid 36241034)
80. Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X (2007) The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 8:247-256. doi: 10.1038/ni1439 (Pubitemid 46745374)
81. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102:3060-3067. doi: 10.1161/01.CIR.102.25.3060
82. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S (2000) Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275:29717-29723. doi: 10.1074/jbc.M003128200 (Pubitemid 32043853)
83. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, Shimizu I, Asahara T, Hamada H, Tomita S, Molkentin JD, Zou Y, Komuro I (2007) p53-Induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444-448. doi: 10.1038/nature05602 (Pubitemid 46474597)
84. Schultz Jel J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR, Doetschman T (2002) TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109:787-796. doi: 10.1172/JCI14190 (Pubitemid 34263155)
85. Schulz R, Panas DL, Catena R, Moncada S, Olley PM, Lopaschuk GD (1995) The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br J Pharmacol 114:27-34. doi: 10.1111/j.1476-5381.1995.tb14901.x
86. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, Kawai-Kowase K, Moriyama N, Imai Y, Kawakami H, Nishimatsu H, Ishikawa T, Suzuki T, Morita H, Maemura K, Sata M, Hirata Y, Komukai M, Kagechika H, Kadowaki T, Kurabayashi M, Nagai R (2002) Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 8:856-863. doi: 10.1038/nm738
87. Siwik DA, Chang DL, Colucci WS (2000) Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86:1259-1265. doi: 10.1161/01.RES.86.12.1259 (Pubitemid 30436667)
88. Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G (2007) Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction. Circ Res 100:140-146. doi: 10.1161/01.RES.0000255031.15793. 86 (Pubitemid 46066782)
89. Sobirin MA, Kinugawa S, Takahashi M, Fukushima A, Homma T, Ono T, Hirabayashi K, Suga T, Azalia P, Takada S, Taniguchi M, Nakayama T, Ishimori N, Iwabuchi K, Tsutsui H (2012) Activation of natural killer T cells ameliorates postinfarct cardiac remodeling and failure in mice. Circ Res 111:1037-1047. doi: 10.1161/CIRCRESAHA.112.270132
90. Sperr WR, Bankl HC, Mundigler G, Klappacher G, Grossschmidt K, Agis H, Simon P, Laufer P, Imhof M, Radaszkiewicz T, Glogar D, Lechner K, Valent P (1994) The human cardiac mast cell: localization, isolation, phenotype, and functional characterization. Blood 84:3876-3884 (Pubitemid 24362488)
91. Sun M, Dawood F, Wen WH, Chen M, Dixon I, Kirshenbaum LA, Liu PP (2004) Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction. Circulation 110:3221-3228. doi: 10.1161/01.CIR.0000147233.10318.23 (Pubitemid 39525069)
92. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo J-L, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ (2009) Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 325:612-616. doi: 10.1126/science.1175202
93. Swirski FK, Nahrendorf M (2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339:161-166. doi: 10.1126/science.1230719
94. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, Nishimura S, Shindo T, Sano M, Otsu K, Snider P, Conway SJ, Nagai R (2010) Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 120:254-265. doi: 10.1172/Jci40295
95. Tang TT, Yuan J, Zhu ZF, Zhang WC, Xiao H, Xia N, Yan XX, Nie SF, Liu J, Zhou SF, Li JJ, Yao R, Liao MY, Tu X, Liao YH, Cheng X (2012) Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol 107:232. doi: 10.1007/s00395-011-0232-6
96. Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van de Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G (2002) Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-α, and sphingosine. Circ Res 90:807-813. doi: 10.1161/01.res.0000014451.75415.36 (Pubitemid 34633897)
97. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27:1201-1206. doi: 10.1016/0735-1097(95)00589-7 (Pubitemid 26117714)
98. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711. doi: 10.1161/01.CIR.93.4.704
99. Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Moriguchi Y, Shibasaki Y, Kamihata H, Inada M, Iwasaka T (1998) Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 83:1035-1046. doi: 10.1161/01.RES.83.10.1035 (Pubitemid 28520933)
100. Turner NA, Porter KE, Smith WH, White HL, Ball SG, Balmforth AJ (2003) Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. Cardiovasc Res 57:784-792. doi: 10.1016/S0008-6363(02)00729-0 (Pubitemid 36254872)
101. Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schutz G, Lumeng CN, Mortensen RM (2010) Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 120:3350-3364. doi: 10.1172/JCI41080
102. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ (2007) Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 170:818-829. doi: 10.2353/ajpath.2007.060547 (Pubitemid 47339352)
103. Venkatachalam K, Mummidi S, Cortez DM, Prabhu SD, Valente AJ, Chandrasekar B (2008) Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol 294:H2078-H2087. doi: 10.1152/ajpheart.01363.2007
104. Volz HC, Laohachewin D, Seidel C, Lasitschka F, Keilbach K, Wienbrandt AR, Andrassy J, Bierhaus A, Kaya Z, Katus HA, Andrassy M (2012) S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kappaB signaling. Basic Res Cardiol 107:250. doi: 10.1007/s00395-012-0250-z
105. Wang J, Xu N, Feng X, Hou N, Zhang J, Cheng X, Chen Y, Zhang Y, Yang X (2005) Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure. Circ Res 97:821-828. doi: 10.1161/01.RES. 0000185833.42544.06 (Pubitemid 41447133)
106. Wei L (2011) Immunological aspect of cardiac remodeling: T lymphocyte subsets in inflammation-mediated cardiac fibrosis. Exp Mol Pathol 90:74-78. doi: 10.1016/j.yexmp.2010.10.004
107. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tschope C (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4:44-52. doi: 10.1161/CIRCHEARTFAILURE.109.931451
108. Yamaoka M, Yamaguchi S, Okuyama M, Tomoike H (1999) Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha. Jpn Circ J 63:951-956. doi: 10.1253/jcj.63.951 (Pubitemid 30002060)
109. Yamazaki T, Komuro I, Yazaki Y (1998) Signalling pathways for cardiac hypertrophy. Cell Signal 10:693-698. doi: 10.1016/S0898-6568(98)00036-9 (Pubitemid 28520021)
110. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL (1997) Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95:1247-1252. doi: 10.1161/01.CIR.95.5.1247 (Pubitemid 27097837)
111. Yoon PO, Lee MA, Cha H, Jeong MH, Kim J, Jang SP, Choi BY, Jeong D, Yang DK, Hajjar RJ, Park WJ (2010) The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis. J Mol Cell Cardiol 49:294-303. doi: 10.1016/j.yjmcc.2010.04.010
112. Yu Q, Horak K, Larson DF (2006) Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 48:98-104. doi: 10.1161/01.HYP.0000227247.27111.b2 (Pubitemid 44297530)
113. Zaglia T, Milan G, Franzoso M, Bertaggia E, Pianca N, Piasentini E, Voltarelli VA, Chiavegato D, Brum PC, Glass DJ, Schiaffino S, Sandri M, Mongillo M (2013) Cardiac sympathetic neurons provide trophic signal to the heart via beta2-adrenoceptor-dependent regulation of proteolysis. Cardiovasc Res 97:240-250. doi: 10.1093/cvr/cvs320
114. Zamilpa R, Kanakia R, Cigarroa J 4th, Dai Q, Escobar GP, Martinez H, Jimenez F, Ahuja SS, Lindsey ML (2011) CC chemokine receptor 5 deletion impairs macrophage activation and induces adverse remodeling following myocardial infarction. Am J Physiol Heart Circ Physiol 300:H1418-H1426. doi: 10.1152/ajpheart.01002.2010
115. Zandbergen HR, Sharma UC, Gupta S, Verjans JW, van den Borne S, Pokharel S, van Brakel T, Duijvestijn A, van Rooijen N, Maessen JG, Reutelingsperger C, Pinto YM, Narula J, Hofstra L (2009) Macrophage depletion in hypertensive rats accelerates development of cardiomyopathy. J Cardiovasc Pharmacol Ther 14:68-75. doi: 10.1177/1074248408329860
116. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R (2007) Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 13:952-961. doi: 10.1038/nm1613 (Pubitemid 47222040)
117. Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD (2000) TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 6:556-563. doi: 10.1038/75037 (Pubitemid 30305906)
118. Zhong Z, Wen Z, Darnell JE Jr (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98. doi: 10.1126/science.8140422 (Pubitemid 24144493)
119. Zucker IH, Liu JL (2000) Angiotensin II-nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail Rev 5:27-43. doi: 10.1023/A:1009894007055 (Pubitemid 30301509)